Edition:
United Kingdom

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

4.99USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$4.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
666,996
52-wk High
$13.41
52-wk Low
$3.81

Chart for

About

ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor... (more)

Overall

Beta: 2.22
Market Cap(Mil.): $768.71
Shares Outstanding(Mil.): 112.22
Dividend: --
Yield (%): --

Financials

  IMGN.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.21 -- --
ROI: -63.15 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates